Creotech Instruments is a Polish company founded in 2012 by alumni of CERN, the European Organization for Nuclear Research. It is quoted on the Warsaw Stock Exchange New Connect market since October 2021. With significant flight heritage, it is developing its own proprietary microsatellite subsystems and platforms for commercial sales from 2023. It is also active in unmanned aerial vehicle (UAV) operation and data analysis. Creotech is one of only a few companies worldwide that is seeking to develop controls for quantum computers and quantum telecommunications. Both areas should augment space segment growth.
Written by
Creotech Instruments |
A leader in Central European SpaceTech
|
SpaceTech – satellites |
QuickView
26 April 2022 |
Share price graph
Share details
Business description
Bull
Bear
Analyst
|
||||||||||||||||||||||
Creotech Instruments is a Polish company founded in 2012 by alumni of CERN, the European Organization for Nuclear Research. It is quoted on the Warsaw Stock Exchange New Connect market since October 2021. With significant flight heritage, it is developing its own proprietary microsatellite subsystems and platforms for commercial sales from 2023. It is also active in unmanned aerial vehicle (UAV) operation and data analysis. Creotech is one of only a few companies worldwide that is seeking to develop controls for quantum computers and quantum telecommunications. Both areas should augment space segment growth.
Building on significant space heritage
Over the last few years, Creotech has developed its own standardised microsatellite platform, HyperSat, which was completed in March 2022. A modular platform using a 40x40x10cm base platform (1HU), the design is larger than CubeSats (1U = 10x10x10cm), therefore allowing greater payloads of up to 60kg and functionality at competitive prices. The first application, EagleEye, is to be deployed in low Earth orbit (LEO) in 2023 as an operational in-orbit technology demonstrator for proprietary systems and third-party instruments. It will carry a telescope providing high-resolution images of Earth. A further three smaller HyperSat microsatellites for the Polish Imaging Satellites (PIAST) mission for the Polish Ministry of National Defence are expected to be deployed in 2024.
Goals for 2025
Management has indicated its main goals to attain by 2025 for the three domains it intends to service: space, Earth atmosphere (UAV) and Earth (quantum controls in the longer term). In space, its first microsatellite deployments next year will support commercial sales of satellites with 10–20 orders anticipated each year. It also aims to become the leading Polish provider of UAV support products by supplying systems such as risk analysis, planning and control for UAV missions. In quantum controls, it aims to be one of only a few suppliers of comprehensive control systems for quantum computers and quantum telecoms, supporting a position as a leading European satellite data integrator in partnership with the EU Agency for the Space Programme and the European Commission. Together with CERN, it is also seeking to develop and launch a sub-nanosecond synchronization system for telecoms.
Growth set to accelerate
The company started 2022 with a sales pipeline of PLN30–35m. It has issued a prospectus with the polish Financial Supervisory Authority in connection with its proposal to transfer to the main market of the Warsaw Stock Exchange during H122 alongside a PLN40–50m funding round (up to 396.6k Series I shares).
|
Historical financials
Source: Company reports |
EDISON QUICKVIEWS ARE NORMALLY ONE OFF PUBLICATIONS WITH NO COMMITMENT TO WRITING ANY FOLLOW UP. QUICKVIEW NOTES USE CONSENSUS EARNINGS ESTIMATES.
|
|
Research: TMT
CentralNic has confirmed that revenue growth driven by Online Marketing continued at a very high level in Q122, with 51% organic revenue growth (LTM pro forma revenues of c US$530m). Management expects Q122 revenues of US$156m (US$624m annualised) and adjusted EBITDA of c US$18m (US$72m annualised). This represents an acceleration from 2021, which saw strengthening organic growth throughout the year (Q121: 16%, H121: 20%, 9M21: 29%, FY21: 39%). As a result, management expects CentralNic to ‘materially exceed’ consensus market expectations for FY22 (revenue US$517m, EBITDA US$60m). We have raised our FY22 gross revenue estimate by 11% to US$573m and our adjusted EBITDA estimate by 9% to US$66m. Based on our revised estimates, CentralNic trades on an FY22 P/E of 9.7x and on 7.3x FY22 EV/adjusted EBITDA.